Company Profile
Purespring Therapeutics Limited
12543677•Private Limited With Share Capital
Get Full Access
01/04/2020
6 years
7
50
72110
very low risk
Company Overview
Registration, classification & business activity
Purespring Therapeutics Limited (12543677) is a private limited with share capital incorporated on 01/04/2020 (6 years old) and registered in london, WC1B3SR. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Purespring, which launched in november 2020 with £45 million of funding from syncona ltd, is the first company to be directly targeting the podocyte, a specialized kidney cell implicated in many kidney diseases, through aav gene therapy. this approach is based on the work of professor moin saleem, p...
Financial Overview
£29.08M
£2.80M
£26.27M
£24.05M
Key Metrics
50
Employees
7
Directors
136
Shareholders
11
Patents
Board of Directors
Risk Assessment
very low risk
International Score
Future Factor
excellent
Performance Rating